DMAC DiaMedica Therapeutics Inc. - Common Stock
$5,68
Prix · Mai 20, 2026
Données fondamentales au Mai 6, 2026
Fourchette 52 semaines
$3–$10
33% of range
Note des analystes
BUY
11 analysts
Objectif de cours
$16
+173% upside
P/E (TTM)
—
ROE
-78.7%
Marge nette
—
DMAC Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$5.68
Capitalisation Boursière
$428M
P/E (TTM)
—
BPA (TTM)
—
Revenus (TTM)
—
Rendement div.
—
ROE
-78.7%
Dette/Capitaux propres
—
Fourchette 52 semaines
$3 – $10
DMAC Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
—
2018-12-31
→
2018-12-31
BPA
—
Flux de trésorerie libre
$-29M
2018-12-31
→
2025-12-31
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
DMAC
Médiane des pairs
P/B
7.6
2.9
Price / FCF (Cours / FCF)
-14.7
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
DMAC
Médiane des pairs
ROA
-60.8%
-46.8%
ROE
-78.7%
-46.0%
ROIC
-61.4%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
DMAC
Médiane des pairs
Current Ratio (Ratio de liquidité)
11.8
8.3
Quick Ratio (Ratio de liquidité réduite)
11.7
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
DMAC
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
DMAC
Médiane des pairs
DMAC Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
11 analystes
- Achat fort 2 18,2%
- Achat 8 72,7%
- Conserver 1 9,1%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
4 analystes · 2026-05-20
Médiane
$13.00
Moyenne
$15.50
← En dessous de tous les objectifs
$5.68
Bas
$11.00
Haut
$25.00
Objectif médian
$13.00
+128,7%
Objectif moyen
$15.50
+172,7%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.00%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.19 | $-0.19 | -0.00% |
| 31 décembre 2025 | $-0.17 | $-0.18 | 0.01% |
| 30 septembre 2025 | $-0.17 | $-0.16 | -0.01% |
| 30 juin 2025 | $-0.18 | $-0.19 | 0.01% |
| 31 mars 2025 | $-0.18 | $-0.18 | 0.00% |
| 31 décembre 2024 | $-0.18 | $-0.18 | -0.00% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| DMAC | $428M | — | — | — | -78.7% | — |
| IMRX | — | -5.2 | — | — | -45.3% | — |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | — |
| TENX | $114M | -9.1 | — | — | -52.5% | — |
| RZLT | $388M | -4.6 | — | — | -56.9% | — |
| RGNX | $733M | -3.8 | 104.5% | -113.8% | -122.5% | — |
| SRZN | — | — | — | — | — | — |
| ABEO | $290M | 5.2 | 147.5% | 1223.1% | 44.1% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 13
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | $500.0K | |
| R&D Expense | $25M | $19M | $13M | $8M | $9M | $8M | $8M | $5M | |
| SG&A Expense | $10M | $8M | $8M | $6M | $5M | $4M | $4M | $3M | |
| Operating Expenses | $34M | $27M | $21M | $14M | $14M | $13M | $12M | $7M | |
| Operating Income | $-34M | $-27M | $-21M | $-14M | $-14M | $-13M | $-12M | $-7M | |
| Interest Income | $2M | $2M | $2M | · | · | · | · | · | |
| Other Non-op | $2M | $2M | $2M | $353.0K | $82.0K | $229.0K | $119.0K | $-68.0K | |
| Pretax Income | $-33M | $-24M | $-19M | $-14M | $-14M | $-12M | $-11M | $-6M | |
| Income Tax | $28.0K | $30.0K | $43.0K | $28.0K | $28.0K | $27.0K | $31.0K | $80.0K | |
| Net Income | $-33M | $-24M | $-19M | $-14M | $-14M | $-12M | $-11M | $-6M | |
| EPS (Basic) | $-0.70 | $-0.60 | $-0.60 | $-0.52 | $-0.65 | · | · | · | |
| Shares (Basic) | 46,980,777 | 40,404,681 | 32,566,723 | 26,443,067 | 20,773,399 | · | · | · | |
| EBITDA | $-34M | $-27M | $-21M | $-14M | $-14M | · | $-12M | $-7M |
Bilan 20
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16M | $3M | $5M | $5M | $5M | $7M | $4M | $17M | |
| Short-term Investments | $44M | $41M | $48M | $29M | $40M | $20M | $4M | · | |
| Receivables | $258.0K | $236.0K | $369.0K | $82.0K | $130.0K | $340.0K | $823.0K | $780.0K | |
| Prepaid Expense | $481.0K | $227.0K | $411.0K | $251.0K | $197.0K | $64.0K | $47.0K | $369.0K | |
| Current Assets | $61M | $45M | $54M | $34M | $45M | $28M | $9M | $18M | |
| PP&E (Net) | $145.0K | $148.0K | $131.0K | $136.0K | $70.0K | $74.0K | $64.0K | $96.0K | |
| PP&E (Gross) | $295.0K | $262.0K | $231.0K | $216.0K | $137.0K | $131.0K | $107.0K | $120.0K | |
| Accum. Depreciation | $150.0K | $114.0K | $100.0K | $80.0K | $67.0K | $57.0K | $43.0K | $24.0K | |
| Total Assets | $61M | $46M | $54M | $34M | $46M | $28M | $9M | $18M | |
| Accounts Payable | $1M | $940.0K | $926.0K | $734.0K | $509.0K | $1M | $182.0K | $483.0K | |
| Accrued Liabilities | $4M | $4M | $2M | $1M | $966.0K | $864.0K | $1M | $808.0K | |
| Current Liabilities | $5M | $5M | $3M | $2M | $2M | $2M | $1M | $1M | |
| Capital Leases | $124.0K | $225.0K | $316.0K | $396.0K | $3.0K | $46.0K | $105.0K | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Paid-in Capital | $229M | $181M | $167M | $128M | $127M | $95M | $64M | $63M | |
| Retained Earnings | $-173M | $-140M | $-116M | $-96M | $-83M | $-69M | $-57M | $-46M | |
| AOCI | $50.0K | $23.0K | $6.0K | $-74.0K | $-51.0K | $-2.0K | $2.0K | · | |
| Stockholders' Equity | $56M | $41M | $51M | $32M | $44M | $26M | $8M | $17M | |
| Liabilities + Equity | $61M | $46M | $54M | $34M | $46M | $28M | $9M | $18M | |
| Shares Outstanding | 53,742,370 | 42,818,660 | 37,958,000 | 26,443,067 | 26,443,067 | 18,746,157 | 12,006,874 | 11,956,874 |
Flux de trésorerie 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $2M | $2M | $2M | $2M | $2M | $1M | $620.0K | |
| Deferred Tax | $0 | $0 | · | · | · | · | · | · | |
| Operating Cash Flow | $-29M | $-22M | $-19M | $-12M | $-12M | $-9M | $-9M | $-6M | |
| CapEx | $40.0K | $25.0K | $24.0K | $81.0K | $22.0K | $47.0K | $2.0K | $50.0K | |
| Investing Cash Flow | $-2M | $9M | $-18M | $12M | $-21M | $-16M | $-4M | $-50.0K | |
| Stock Issued | $43M | $12M | $37M | $0 | $30M | $29M | · | $15M | |
| Net Stock Activity | $43M | $12M | $37M | $0 | $30M | · | · | $15M | |
| Financing Cash Flow | $44M | $12M | $37M | $-6.0K | $30M | $29M | $70.0K | $21M | |
| Net Change in Cash | $13M | $-2M | $-185.0K | $21.0K | $-3M | $4M | $-13M | $15M | |
| Free Cash Flow | $-29M | $-22M | $-19M | $-12M | $-12M | · | $-9M | $-6M |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | -1352.2% | |
| Net Margin | · | · | · | · | · | · | · | -1146.8% | |
| Pretax Margin | · | · | · | · | · | · | · | -1130.8% | |
| EBITDA Margin | · | · | · | · | · | · | · | -1352.2% | |
| ROA | -60.8% | -48.6% | -43.8% | -34.2% | -36.9% | · | -77.8% | -56.9% | |
| ROE | -78.7% | -55.1% | -36.3% | -40.9% | -29.8% | · | -123.0% | -54.3% | |
| ROIC | -61.4% | -65.6% | -41.8% | -44.1% | -31.1% | · | -152.6% | -40.3% |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.8 | 8.3 | 19.3 | 15.6 | 29.8 | · | 6.7 | 13.9 | |
| Quick Ratio | 11.7 | 8.2 | 19.1 | 15.5 | 29.7 | · | 6.6 | 13.6 |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | 1.2 |
Valorisation (TTM) 8
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | $500.0K | |
| Net Income TTM | $-33M | $-24M | $-19M | $-14M | $-14M | $-12M | $-11M | $-6M | |
| Market Cap | $428M | $233M | $108M | $42M | $99M | · | $58M | $35M | |
| P/S | · | · | · | · | · | · | · | 69.6 | |
| P/B | 7.6 | 5.7 | 2.1 | 1.3 | 2.2 | · | 7.6 | 2.0 | |
| P / Tangible Book | 7.6 | 5.7 | 2.1 | 1.3 | 2.2 | 7.3 | · | · | |
| P / Cash Flow | -14.7 | -10.5 | -5.8 | -3.6 | -8.1 | · | -6.4 | -6.1 | |
| P / FCF | -14.7 | -10.5 | -5.7 | -3.6 | -8.0 | · | -6.4 | -6.1 |
Compte de résultat 11
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $8M | $7M | $6M | $6M | $6M | $6M | $5M | $4M | $4M | $4M | $3M | $3M | $4M | $2M | $2M | $2M | |
| SG&A Expense | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Operating Income | $-10M | $-9M | $-9M | $-8M | $-8M | $-8M | $-7M | $-6M | $-6M | $-6M | $-5M | $-5M | $-6M | $-4M | $-3M | $-3M | |
| Interest Income | $470.0K | $472.0K | $440.0K | $313.0K | $444.0K | $543.0K | $618.0K | $524.0K | $616.0K | · | · | · | · | · | · | · | |
| Other Non-op | $447.0K | $1M | $-21.0K | $1.0K | $443.0K | $2M | $-2.0K | $2.0K | $597.0K | $709.0K | $693.0K | $271.0K | $256.0K | $229.0K | $76.0K | $13.0K | |
| Pretax Income | $-10M | $-9M | $-9M | $-8M | $-8M | $-8M | $-6M | $-5M | $-5M | $-5M | $-4M | $-4M | $-5M | $-4M | $-3M | $-3M | |
| Income Tax | $7.0K | $10.0K | $6.0K | $6.0K | $6.0K | $9.0K | $7.0K | $7.0K | $7.0K | $22.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | |
| Net Income | $-10M | $-9M | $-9M | $-8M | $-8M | $-8M | $-6M | $-5M | $-5M | $-5M | $-4M | $-4M | $-5M | $-4M | $-3M | $-3M | |
| EPS (Basic) | $-0.19 | $-0.17 | $-0.17 | $-0.18 | $-0.18 | $-0.18 | $-0.15 | $-0.13 | $-0.14 | $-0.12 | $-0.12 | $-0.16 | $-0.20 | $-0.14 | $-0.12 | $-0.13 | |
| Shares (Basic) | 53,793,490 | -88,450,899 | 49,630,119 | 42,957,619 | 42,843,938 | -78,373,274 | 42,751,577 | 38,068,378 | 37,958,000 | -59,143,648 | 37,949,422 | 27,312,008 | 26,448,941 | -52,886,134 | 26,443,067 | 26,443,067 | |
| EBITDA | $-10M | · | $-9M | $-8M | $-8M | · | $-7M | $-6M | $-6M | · | $-5M | $-5M | $-6M | · | $-3M | $-3M |
Bilan 20
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $16M | $3M | $4M | $3M | $3M | $4M | $14M | $2M | $5M | $2M | $6M | $2M | $5M | $3M | $3M | |
| Short-term Investments | $46M | $44M | $52M | $26M | $34M | $41M | $46M | $40M | $44M | $48M | $44M | $35M | $27M | $29M | $33M | $35M | |
| Receivables | $301.0K | $258.0K | $260.0K | $161.0K | $253.0K | $236.0K | $290.0K | $391.0K | $399.0K | $369.0K | $310.0K | $188.0K | $57.0K | $82.0K | $75.0K | $88.0K | |
| Prepaid Expense | $731.0K | $481.0K | $445.0K | $680.0K | $649.0K | $227.0K | $280.0K | $568.0K | $569.0K | $411.0K | $1M | $675.0K | $962.0K | $251.0K | $322.0K | $534.0K | |
| Current Assets | $52M | $61M | $56M | $31M | $37M | $45M | $51M | $55M | $47M | $54M | $48M | $41M | $30M | $34M | $36M | $39M | |
| PP&E (Net) | $142.0K | $145.0K | $150.0K | $152.0K | $149.0K | $148.0K | $151.0K | $152.0K | $132.0K | $131.0K | $135.0K | $133.0K | $136.0K | $136.0K | $110.0K | $74.0K | |
| PP&E (Gross) | $301.0K | $295.0K | $289.0K | $280.0K | $271.0K | $262.0K | $254.0K | $250.0K | $238.0K | $231.0K | $232.0K | $222.0K | $219.0K | $216.0K | $183.0K | $141.0K | |
| Accum. Depreciation | $159.0K | $150.0K | $139.0K | $128.0K | $122.0K | $114.0K | $103.0K | $98.0K | $106.0K | $100.0K | $97.0K | $89.0K | $83.0K | $80.0K | $73.0K | $67.0K | |
| Total Assets | $53M | $61M | $57M | $31M | $39M | $46M | $53M | $57M | $49M | $54M | $58M | $62M | $30M | $34M | $37M | $39M | |
| Accounts Payable | $3M | $1M | $2M | $1M | $2M | $940.0K | $1M | $759.0K | $716.0K | $926.0K | $863.0K | $856.0K | $2M | $734.0K | $864.0K | $624.0K | |
| Accrued Liabilities | $2M | $4M | $3M | $3M | $3M | $4M | $3M | $2M | $2M | $2M | $1M | $1M | $956.0K | $1M | $637.0K | $894.0K | |
| Current Liabilities | $6M | $5M | $5M | $4M | $5M | $5M | $4M | $3M | $3M | $3M | $2M | $2M | $3M | $2M | $2M | $2M | |
| Capital Leases | $96.0K | $124.0K | $150.0K | $176.0K | $201.0K | $225.0K | $249.0K | $272.0K | $294.0K | $316.0K | $337.0K | $4.0K | $4.0K | $396.0K | $415.0K | · | |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Paid-in Capital | $230M | $229M | $216M | $183M | $182M | $181M | $180M | $179M | $167M | $167M | $166M | $166M | $128M | $128M | $128M | $127M | |
| Retained Earnings | $-183M | $-173M | $-164M | $-155M | $-148M | $-140M | $-132M | $-126M | $-121M | $-116M | $-110M | $-106M | $-101M | $-96M | $-92M | $-89M | |
| AOCI | $-26.0K | $50.0K | $50.0K | $-14.0K | $5.0K | $23.0K | $81.0K | $-51.0K | $-39.0K | $6.0K | $-127.0K | $-63.0K | $-29.0K | $-74.0K | $-162.0K | $-167.0K | |
| Stockholders' Equity | $47M | $56M | $52M | $27M | $34M | $41M | $48M | $53M | $46M | $51M | $56M | $60M | $27M | $32M | $35M | $38M | |
| Liabilities + Equity | $53M | $61M | $57M | $31M | $39M | $46M | $53M | $57M | $49M | $54M | $58M | $62M | $30M | $34M | $37M | $39M | |
| Shares Outstanding | 53,883,345 | 53,742,370 | 52,077,439 | 43,072,488 | 42,859,465 | 42,818,660 | 42,766,497 | 42,692,582 | 37,963,916 | 37,958,000 | 37,953,711 | 37,949,422 | 26,464,977 | 26,443,067 | 26,443,067 | 26,443,067 |
Flux de trésorerie 8
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $822.0K | $1M | $1M | $771.0K | $867.0K | $589.0K | $565.0K | $443.0K | $488.0K | $456.0K | $425.0K | $380.0K | $422.0K | $411.0K | $418.0K | $365.0K | |
| Operating Cash Flow | $-9M | $-8M | $-7M | $-8M | $-7M | $-6M | $-4M | $-5M | $-7M | $-4M | $-5M | $-5M | $-5M | $-3M | $-2M | $-2M | |
| CapEx | $8.0K | $6.0K | $16.0K | $6.0K | $12.0K | $7.0K | $9.0K | $0 | $9.0K | $3.0K | $10.0K | $4.0K | $7.0K | $32.0K | $43.0K | $6.0K | |
| Investing Cash Flow | $-2M | $8M | $-26M | $9M | $7M | $5M | $-6M | $5M | $4M | $6M | $1M | $-28M | $3M | $5M | $2M | $3M | |
| Stock Issued | · | $12M | $32M | · | · | $0 | $0 | · | · | $0 | $-4.0K | · | · | $0 | $0 | · | |
| Financing Cash Flow | $417.0K | $12M | $32M | $161.0K | $91.0K | $120.0K | $123.0K | $12M | $-1.0K | $-1.0K | $-6.0K | $37M | $-1.0K | $-1.0K | $-2.0K | $-2.0K | |
| Net Change in Cash | $-11M | $12M | $-783.0K | $2M | $-436.0K | $-1M | $-10M | $12M | $-2M | $2M | $-4M | $4M | $-3M | $2M | $-291.0K | $30.0K | |
| Free Cash Flow | $-9M | · | · | · | $-7M | · | · | · | $-7M | · | · | · | $-5M | · | · | · |
Rentabilité 3
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -21.9% | · | -15.7% | -17.4% | -17.5% | · | -11.3% | -8.6% | -13.0% | · | -9.4% | -8.8% | -14.6% | · | -7.1% | -11.0% | |
| ROE | -24.7% | · | -17.3% | -19.1% | -19.2% | · | -12.1% | -9.0% | -14.0% | · | -9.9% | -9.2% | -15.6% | · | -7.4% | -11.6% | |
| ROIC | -22.2% | · | -17.5% | -29.5% | -24.0% | · | -14.4% | -10.6% | -12.4% | · | -9.3% | -8.0% | -20.5% | · | -8.9% | -8.9% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.1 | · | 10.7 | 7.6 | 8.0 | · | 11.8 | 17.8 | 18.1 | · | 22.1 | 21.2 | 10.5 | · | 23.7 | 25.5 | |
| Quick Ratio | 9.0 | · | 10.6 | 7.3 | 7.8 | · | 11.7 | 17.6 | 17.9 | · | 21.6 | 20.8 | 10.2 | · | 23.4 | 25.1 |
Valorisation (TTM) 6
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-34M | · | $-30M | $-27M | $-24M | · | $-21M | $-19M | $-19M | · | $-17M | $-16M | $-15M | · | $-13M | $-14M | |
| Market Cap | $365M | · | $358M | $168M | $162M | · | $179M | $126M | $105M | · | $98M | $164M | $40M | · | $33M | $53M | |
| P/B | 7.7 | · | 6.9 | 6.2 | 4.8 | · | 3.7 | 2.4 | 2.3 | · | 1.8 | 2.7 | 1.5 | · | 0.9 | 1.4 | |
| P / Tangible Book | 7.7 | · | 6.9 | 6.2 | 4.8 | · | 3.7 | 2.4 | 2.3 | · | 1.8 | 2.7 | 1.5 | · | 0.9 | 1.4 | |
| P / Cash Flow | -40.2 | · | · | · | -22.7 | · | · | · | -15.8 | · | · | · | -8.0 | · | · | · | |
| P / FCF | -40.1 | · | · | · | -22.7 | · | · | · | -15.8 | · | · | · | -7.9 | · | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Résultat net | $-33M | $-24M | $-19M | $-14M | $-14M |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 11.8 | 8.3 | 19.3 | 15.6 | 29.8 |
| Ratio de liquidité réduite | 11.7 | 8.2 | 19.1 | 15.5 | 29.7 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-29M | $-22M | $-19M | $-12M | $-12M |
Dernières actualités Actualités récentes mentionnant cette entreprise
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.